Literature DB >> 34213662

A metal-free salalen ligand with anti-tumor and synergistic activity in resistant leukemia and solid tumor cells via mitochondrial pathway.

Sina M Hopff1, Qifang Wang2, Corazon Frias3, Marie Ahrweiler3, Nicola Wilke3, Nathalie Wilke3, Albrecht Berkessel2, Aram Prokop3,4,5.   

Abstract

PURPOSE: Since the discovery of the well-known cis-platin, transition metal complexes are highly recognized as cytostatic agents. However, toxic side effects of the metal ions present in the complexes may pose significant problems for their future development. Therefore, we investigated the metal-free salalen ligand WQF 044.
METHODS: DNA fragmentations in leukemia (Nalm6) and solid tumor cells (BJAB, MelHO, MCF-7, RM82) proved the apoptotic effects of WQF 044, its overcoming of resistances and the cellular pathways that are affected by the substance. The apoptotic mechanisms finding were supported by western blot analysis, measurement of the mitochondrial membrane potential and polymerase chain reactions.
RESULTS: A complex intervention in the mitochondrial pathway of apoptosis with a Bcl-2 and caspase dependence was observed. Additionally, a wide range of tumors were affected by the ligand in a low micromolar range in-vitro. The compound overcame multidrug resistances in P-gp over-expressed acute lymphoblastic leukemia and CD95-downregulated Ewing's sarcoma cells. Quite remarkable synergistic effects with vincristine were observed in Burkitt-like lymphoma cells.
CONCLUSION: The investigation of a metal-free salalen ligand as a potential anti-cancer drug revealed in promising results for a future clinical use.

Entities:  

Keywords:  Apoptosis; Metal-free ligand; Mitochondrial pathway; Multidrug resistance; Salalen; Synergistic effects

Year:  2021        PMID: 34213662     DOI: 10.1007/s00432-021-03679-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  62 in total

Review 1.  The Bcl-2 protein family.

Authors:  B Antonsson; J C Martinou
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

2.  Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.

Authors:  S J Cotterill; S Ahrens; M Paulussen; H F Jürgens; P A Voûte; H Gadner; A W Craft
Journal:  J Clin Oncol       Date:  2000-09       Impact factor: 44.544

3.  Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro.

Authors:  Maxim Dragoun; Thomas Günther; Corazon Frias; Albrecht Berkessel; Aram Prokop
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-27       Impact factor: 4.553

Review 4.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

5.  Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazole.

Authors:  Rodrigo S Corrêa; Monize M da Silva; Angelica E Graminha; Cássio S Meira; Jamyle A F Dos Santos; Diogo R M Moreira; Milena B P Soares; Gustavo Von Poelhsitz; Eduardo E Castellano; Carlos Bloch; Marcia R Cominetti; Alzir A Batista
Journal:  J Inorg Biochem       Date:  2016-01-02       Impact factor: 4.155

Review 6.  BCL-2 proteins and apoptosis: Recent insights and unknowns.

Authors:  Frank Edlich
Journal:  Biochem Biophys Res Commun       Date:  2017-07-01       Impact factor: 3.575

7.  Low-intensity therapy in adults with Burkitt's lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Margaret Shovlin; Seth M Steinberg; Diane Cole; Cliona Grant; Brigitte Widemann; Louis M Staudt; Elaine S Jaffe; Richard F Little; Wyndham H Wilson
Journal:  N Engl J Med       Date:  2013-11-14       Impact factor: 91.245

8.  The Human Transient Receptor Potential Melastatin 2 Ion Channel Modulates ROS Through Nrf2.

Authors:  Lei Bao; Fernanda Festa; Christopher S Freet; John P Lee; Iwona M Hirschler-Laszkiewicz; Shu-Jen Chen; Kerry A Keefer; Hong-Gang Wang; Andrew D Patterson; Joseph Y Cheung; Barbara A Miller
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

Review 9.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

10.  Cell death stages in single apoptotic and necrotic cells monitored by Raman microspectroscopy.

Authors:  Eva Brauchle; Sibylle Thude; Sara Y Brucker; Katja Schenke-Layland
Journal:  Sci Rep       Date:  2014-04-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.